Abbreviated New Drug Application (ANDA) provides a 180-day period of exclusivity to the first applicant who files for ANDA containing a paragraph IV certification to a listed patent.
An abbreviated new drug application (ANDA) covers data which is submitted to USFDA for the review & approval of a generic pharmaceutical drug. Once the generic drug manufacturing company gets the approval it can manufacture & sell the generic drug.
Information provided by Chemxpert for Abbreviated New Drug Application (ANDA)
For Example: In our database (Chemxpert) Paracetamol has 39 Formulated products available in Abbreviated New Drug Application (ANDA).